Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2022-02-21 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
This is in continuation to the outcome of the Board meeting dated 17th February, 2022 wherein we had informed to the stock exchanges about the appointment of a) Mr. Binod Chandra Maharana ....
Regulatory Filings
2022-02-21 English
Issue of Securities
Board/Management Information Classification · 95% confidence The document is a detailed announcement from Wanbury Limited regarding the outcome of a Board Meeting held on 17th February 2022. It includes multiple items such as the appointment of independent directors for a second term, issuance of convertible warrants on a preferential basis, and grant of stock options to employees. The document references compliance with SEBI Listing Regulations and includes annexures with detailed profiles of the appointed directors and terms of the preferential issue and ESOP grant. The content focuses on board decisions and management appointments rather than financial results or audit opinions. Therefore, the document fits best under 'Board/Management Information' (MANG) as it announces changes in the company's board and management structure and related corporate actions. The document length and detail confirm it is not a brief announcement or a report publication notice but a substantive filing about board decisions and appointments.
2022-02-17 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a detailed announcement from Wanbury Limited regarding the outcome of a Board Meeting held on 17th February 2022. It includes multiple items such as the appointment of independent directors, issuance of convertible warrants on a preferential basis, and grant of stock options to employees. The document references compliance with SEBI Listing Regulations and includes annexures with detailed profiles of appointed directors and terms of the preferential issue and ESOP grant. The content focuses on board decisions and appointments rather than financial results or audit opinions. Therefore, this document fits best under 'Board/Management Information' (MANG) as it announces changes in the company's board and management-related decisions. The document length is substantial and contains detailed information, not just a brief announcement or report publication notice, supporting classification as MANG rather than RPA or RNS.
2022-02-17 English
Outcome of the Board Meeting held on 17th February, 2022 in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) ....
Regulatory Filings
2022-02-17 English
Outcome of the Board Meeting held on 17th February, 2022 in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) ....
Regulatory Filings
2022-02-17 English
Board Meeting — Fund Raising
Regulatory Filings Classification · 90% confidence The document is extremely short (479 characters) and contains only an address and listing information for stock exchanges without any substantive content or financial data. There is no indication of a report, announcement, or detailed filing. It appears to be a brief communication or cover letter without report content. Given the lack of detailed information and the short length, this fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2022-02-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.